Medtronic seeks arbitration in catheter patent row
This article was originally published in Clinica
Medtronic AVE, which is facing a patent suit from Boston Scientific over the rapid exchange delivery system used in its S670 coronary stent system, says that it will go to court to force Boston Scientific to choose arbitration rather than legal action to solve the dispute.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.